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introDuction
For patients with advanced stage, non-metastasized naso-
pharyngeal carcinoma (NPC) and esophageal cancer concur-
rent chemoradiation ais an integral part of curative intended 
therapy. Especially for those long treatment volumes, exact 
patient positioning is of high impact to ensure that the whole 
treatment volume is covered with the prescribed dose.
A conventional linear accelerator treatment couch allows 
manipulation of the patient in four degrees of freedom 
(DoF) [three translational degrees (xyz) and rotational 
degree yaw (rotation around sagittal axis)]. However, the 
rotational degrees pitch (rotation around the transversal 
axis) and roll (rotation around the longitudinal axis) are 
often not addressed.
Several publications have shown that rotational errors 
have a small impact on the dose distribution in the case 
of irradiation of small spherical volumes, such as brain 
metastases or prostates.1–6 Peng et al showed that a rota-
tional error of 3° reduces coverage of the clinical target 
volume in brain tumors treated with intensity modu-
lated radiotherapy from 99.3 to 97.0%.1 Similarly, Guck-
enberger et al concluded that rotational errors do not 
affect target coverage and conformity in brain metastases 
using volumetric arc therapy (VMAT) or static beams.4 
However, for geometrical reasons the impact of pitch 
might be more relevant in the case of long treatment 
volumes, because dose coverage might be compromised 
at the edges of the cranial or caudal end of the target 
volume and high doses might be shifted into organs at risk 
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objective: Pitch, the rotation around the transversal 
axis of the patient during radiotherapy has little impact 
on the dose distribution of small spherical treatment 
volumes; however it might affect treatment of long 
volumes requiring a correction with a six degree of 
freedom couch. 
Methods: We included 10 patients each with nasopharyn-
geal carcinoma (NPC) and esophageal cancer, treated 
with volumetric modulated arc therapy. Pitch was simu-
lated by tilting the planning CT in ventral and dorsal direc-
tion by ± 1.5° and ± 3°. Verification plans were calculated 
on the tilted datasets and were compared to the original 
plan and the dose constraints of the organs at risk (OAR). 
results: The deviation in dose to the planning target 
volume is increasing with the degree of pitch with 
mean changes of up to 2% for NPC and 1% for esoph-
ageal cancer. The most affected OAR in NPC patients 
are brainstem (max. dose +6.0%) and spinal cord (max. 
dose +10.0%) when tilted by 3° dorsally and lenses 
(max. dose +3.3%), oral mucosa (mean dose +2.6%) 
and parotid glands (mean dose +4.3%) when tilted by 
3° ventrally. For esophageal cancer patients, there was 
no significant change in dose to any OAR. Whereas for 
esophageal cancer, all tilted treatment plans were still 
clinically acceptable regarding OAR, 5 NPC plans would 
no longer be acceptable with a pitch of 1.5° ventral (N = 
1), 3° ventral (N = 2) and 3° dorsal (N = 2). 
conclusion: Planning target volume coverage in both 
tumor entities was only slightly affected, but pitch errors 
could be relevant for OAR in NPC patients. 
advances in knowledge: A correction with a six degree 
of freedom couch is recommended for NPC patients with 
a pitch mismatch of more than 1.5° to avoid exceeded 
doses to the OAR.
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(OAR). This becomes even more important considering the 
fact that nowadays, more and more intensity modulated radia-
tion techniques are used, which produce highly conformal and 
complex dose distributions. There exists only limited data on 
the impact of a pitch on long treatment volumes.
Radiotherapy of head and neck and esophageal cancers are exam-
ples of extended treatment volumes. Patients with head and neck 
cancer may have rotational variations of up to 14° during the 
course of radiotherapy.7 Mean deviations in pitch, roll and yaw of 
head and neck cancer patients amount to 0.5° ± 2.3°, 1.4° ± 3.2° 
and 0.5° ± 1.6°, respectively.8 Similar deviations are reported by 
other authors.7,9–12 Chen et al evaluated rotational set-up errors 
of esophageal cancer patients and found errors of up to 6.2° with 
mean differences of 1.0° ± 0.5°, 1.2° ± 1.2° and 1.1° ± 0.8° for 
pitch, roll and yaw, respectively.13 According to mathematical 
calculations, a rotational error of 1.5° leads to misalignment at 
the edges of a 20 cm long planning target volume (PTV) of 2.6 
mm and an error of 3° to a misalignment of 5.2 mm. Nowadays 
several robotic add-on systems for corrections in 6DoF are avail-
able to compensate for these rotational variations (e.g. Perfect-
PitchTM 6DoF couch (Varian Medical Systems, Palo Alto, CA), 
HexaPODTM evo RT system (Elekta AB, Stockholm, Sweden), 
ProturaTM Robotic Patient Positioning System (CIVCO Medical 
Solutions, Coralville, IA etc.). In this study, we investigated the 
dosimetric influence of pitch for long treatment volumes such 
as nasopharyngeal carcinoma and esophageal cancer treated 
with VMAT. Dosimetric differences in the PTV and relevant 
OAR due to a pitch of 1.5° and 3° were evaluated and the degree 
of mismatch at which the patient should be repositioned or 
corrected with the use of a 6DoF couch to avoid exceeded doses 
to the OAR was assessed.
MethoDS anD MaterialS/patientS
Patient selection
Altogether, 20 patients have been retrospectively included in 
this study: 10 patients with NPC and 10 patients with esopha-
geal cancer. All patients were treated with VMAT at the Univer-
sity Hospital Zurich between 2010 and 2013. Patients with 
NPC have been randomly chosen from an internal database. In 
the case of esophageal cancer, patients with a long PTV in the 
craniocaudal direction were selected (for patient details Table 1). 
Specific exclusion criteria were not applied. Patients with NPC 
were treated with 66–70 Gy in 33–35 fractions and esophageal 
cancer patients with 41.4–54 Gy in 23–28 fractions. Treatment 
volumes were created as follows: In the case of NPC the gross 
tumor volume was expanded by 1 cm and adapted anatomically 
(max. 3 mm beyond anatomical boundaries) to create the 66–70 
Gy PTV (PTV1). 69.6–70 Gy was the standard dose adminis-
tered, whereas 66 Gy was given in case of large high-dose treat-
ment volumes. The entire nasopharynx as area of high risk for 
microscopic disease received at least 60 Gy (intermediary dose 
volume, PTV2) and the elective cervical lymph nodes, usually 
level II–V bilaterally, 54 Gy (PTV3). In the case of esophageal 
cancer the gross tumor volume was expanded by 1.5 cm axially, 
adapted to vertebral bodies, and 4 cm craniocaudally, added by 
the locoregional lymph nodes [paraesophageal, celiac (cancer of 
lower esophagus), supraclavicular (cancer of upper esophagus)]
to create the PTV. The maximal length of PTV in NPC ranged 
from 4.7 to 13.7 cm for PTV1 and 11.7–23.0 cm for the sum of 
the PTVs; in esophageal cancer, the PTV ranged from 20.4 to 
31.6 cm.
Treatment planning
VMAT treatment planning was performed in Eclipse treatment 
planning system (TPS) (v.  11, Varian Medical Systems, Palo Alto, 
CA) using progressive resolution optimizer (PRO 11.0.31). Dose 
was calculated using the analytic anisotropic algorithm (AAA 
11.0.31). Depending on the complexity of the PTV, 2–4 coplanar 
arcs were used. For esophageal cancer, avoidance sectors were 
used to spare the lungs.
Table 1.  Patient and treatment parameters
NPC Esophageal cancer 
N N
Stage
  II 3 (30%) 2 (20%) 
  III 4 (40%) 6 (60%) 
  IV 3 (30%) 2 (20%) 
Dose prescription NPC
  70 Gy/35 fx  6 (60%) 
  69.6 Gy/33 fx 2 (20%) 
  68 Gy/34 fx 1 (10%) 
  66 Gy/33 fx 1 (10%) 
Dose prescription esophageal cancer  
  54 Gy/27 fx 1 (10%) 
  50.4 Gy/28 fx 1 (10%) 
  50 Gy/25 fx 2 (20%) 
  45 Gy/25 fx 1 (10%) 
  41.4 Gy/23 fx 4 (40%) 
Size high dose PTV 
  Mean [cm3]/Median 
[cm3] 
197.1/191.5 1159.6/1072.7 
  SD [cm3] 68.9 321.6 
  Range [cm3] 98.4–339.1 862.0–1764.4 
Max. length PTV  
  Mean [cm] / Median 
[cm] 
20.0/20.6 25.5/24.6 
  SD [cm] 3.2 3.7 
  Range [cm] 11.7–23.0 20.4–31.6 
Arcs  
  2 8 (80%) 8 (80%) 
  3 1 (10%) 2 (20%) 
  4 1 (10%) 
fx, fractions; N, number of patients if not indicated otherwise; 
NPC, nasopharyngeal carcinoma; PTV, planning target volume; SD, 
standard deviation
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All patients were treated on a Trilogy or TrueBeam linear acceler-
ator (Varian Medical Systems, Palo Alto, CA). Patients with NPC 
were fixated with a 5-point head and neck immobilization mask 
(Civco Medical Solutions, Armonk, NY). Patients with esopha-
geal cancer were positioned supine on the treatment table using a 
wing board for arm positioning. Image guidance was performed 
for all patients using daily orthogonal kilovoltage (kV) image 
pairs and at least once per week kV cone beam CT(CBCT). For 
both treatment sites, the aim was to cover 95% of the PTV with 
at least 95% of the prescribed dose (V95%). However, in cases 
where air cavities or lung tissue were included in the PTV, the 
PTV was close to the surface or in order to reduce the dose to the 
OAR, reduced PTV coverage was accepted.
The mandatory dose constraints for OAR in patients with NPC 
were a maximum dose to the spinal cord of 50 Gy, a maximum 
dose to the optical nerves and chiasm of 54 Gy, a maximum dose 
to the brainstem of 60 Gy and a mean dose to the parotid glands 
of 26 Gy and to the lenses of 5 Gy. For esophageal cancer, the dose 
constraints for OAR were a maximum dose to the spinal cord of 
45 Gy and a mean dose to the lungs of 20 Gy. For both sites other 
OAR (brain, eyes, lacrimal glands, oral mucosa, cochlea, heart) 
have been optimized in respect to the accumulated dose, to meet 
the institutional dose standards as good as possible (Table 2).
Reference plans
Pitch was simulated by tilting the planning CT around the trans-
versal axis in ventral and dorsal direction by ± 1.5° and ± 3° 
(Figure 1). The value of 3° was chosen, because it is the largest 
adjustment that can be performed with most commercially avail-
able 6DoF couches. In addition, 1.5° was chosen based on our 
clinical experience that this degree of pitch frequently occurs. 
First, a copy of the original CT data set was made in the TPS, 
identifying DICOM tags were deleted with Matlab v. 8.2 (Math-
works, Natick, MA) and PTV structures and structures of OAR 
were copied onto the CT data  set, again in the TPS. Then, the 
data set was tilted with all the structures in the TPS around the 
middle of the dens axis for nasopharyngeal volumes and around 
the geometric middle of the PTV for esophageal volumes. Then, 
respective plans with the same pre-set values were calculated on 
the four tilted data sets for each patient.
PTV coverage and mean and maximum dose to the OAR were 
compared to the original plan and to the dose constraints of the 
OAR. In the case of NPC, the following OAR were evaluated: 
brain, brainstem, chiasm, optical nerves, spinal cord, lenses, oral 
mucosa and parotid glands. For esophageal cancer, spinal cord, 
lungs, heart, liver, intestines and kidneys were analyzed as OAR.
Statistical analysis
Statistical analysis was done using the software program SPSS v. 
22 (IBM SPSS Statistic Software, Armonk, NY). Differences in 
mean and maximum dose to PTVs and OAR were calculated and 
mean, median and range of these differences were determined. 
Box-Whisker-Plots for OAR and line charts for PTVs were 
created to show dosimetric changes in these structures in the 
tilted treatment plans. The two-sided Wilcoxon signed-rank test 
was used to test whether the differences between the maximum 
Table 2.  Institutional dose constraints of organs at risk for 
NPC and esophageal cancer patients
Maximum dose Mean dose
NPC 
  Brainstem 60 Gy
  Optic nerves/Chiasm 54 Gy
  Lens 5 Gy
  Spinal cord 50 Gy
  Brain As low as possible
  Eyes 54 Gy
  Lacrimal gland 45 Gy
  Parotid gland 26 Gy
  Oral mucosa As low as possible
   Cochlea 45 Gy
Esophageal cancer 
  Spinal cord 45 Gy
  Lungs 20 Gy
  Heart As low as possible
NPC, nasopharyngeal carcinoma.
Figure 1.  Schema of pitch in ventral and dorsal direction in a 
patient with NPC. The grey line represents the high dose PTV. 
High dose PTV as contour in grey. NPC, nasopharyngeal carci-
noma; PTV, planning target volume.
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and mean dose of the PTVs and OAR and the PTV coverage of 
the tilted plans compared to the original plan were statistically 
significant to a p-value of ≤0.05.
reSultS
Planning target volume
Figure  2a shows the changes in mean and maximum dose to 
the PTV of the 10 NPC patients tilted ventrally and dorsally 
by 1.5° and 3°. Deviation in dose to the PTV is increasing with 
the degree of pitch, but the effect appears to be relatively small 
(mean deviation below 3%). Whereas the mean and maximum 
dose to the PTV1 is nearly constant, the mean V95% of PTV1 
varied by a mean value of up to 2.6% with a pitch of 3° ventrally. 
The average mean and maximum dose to the PTV3 and average 
V95% of PTV3 changed at maximum by 2.0%. For one patient, a 
deviation of 9.2% for the maximum value of PTV3 was recorded 
when tilted by 3° dorsally. In this patient, there was a hotspot at 
the border of PTV1, which was shifted into PTV3.
For esophageal cancer patients, a pitch of 1.5° and 3° resulted in 
even less variation in dose to the PTV and PTV coverage with 
mean changes of up to 0.9% when tilted ventrally (Figure 2b). 
Statistically significant changes could only be detected for 
maximum dose to the PTV when tilted by 3° dorsally (p = 0.038) 
and for PTV V95% when tilted by 3° ventrally (p = 0.013).
Organs at risk
The OAR most affected by a change of the pitch angle in NPC 
patients were brainstem, spinal cord, lenses, oral mucosa and 
parotid glands (Table 3, Figure 3), with dose variations of up to 
35% in the optical nerves of one patient. Statistically significant 
mean dose deviations ranged up to 10.0% for the maximal dose 
to the spinal cord. An example of a patient that had a huge change 
in the dose to the brainstem due to the location close to the high 
dose PTV1 is shown in Figure 4. The mean dose to the brain and 
the mean and maximum dose to the chiasm and optical nerves 
did not change significantly when the head was tilted ventrally 
or dorsally by 1.5° and 3°. The initial non-tilted plan met in 6/10 
cases our institutional OAR tolerances. Two plans exceeded the 
tolerance dose of the brainstem (max. dose of 62.5 and 63.0 Gy, 
respectively) because the PTV was located less than 5 mm away 
from it. In another initial plan. the dose to the ipsilateral optical 
nerve (max. dose of 61.8 Gy) was exceeded since it was located 
adjacent to the PTV. In the last case, the PTV including posi-
tive lymph nodes at both sides of the neck was located over the 
whole length of the parotid glands and therefore exceeded their 
tolerance dose (mean dose left 28.8 Gy and right 27.3 Gy, respec-
tively). With a pitch of ± 1.5° and ± 3°, all patients who initially 
exceeded the tolerance dose of at least one OAR also exceeded 
the tolerance dose in the tilted plans. Two more patients, whose 
plans were initially below the dose constraints, exceeded the 
OAR tolerance dose at 1.5° ventral (N = 1), 3° ventral (N = 2) 
and 3° dorsal (N = 2). Altogether, 21/40 tilted NPC treatment 
plans would no longer be acceptable according to at least one of 
the dose constraints of the OAR (number of plans exceeding the 
dose constraints according to pitch: 0°: N = 4; +1.5°: N = 5;  −1.5°: 
N = 4; +3°: N = 6; −3°: N = 6).
For esophageal cancer patients, there was no significant change 
in dose to any OAR. The largest difference was found for the 
maximum dose to the bowel with a deviation of +1.0% when 
tilted by 3° ventrally. None of the OAR exceeded the organ toler-
ance due to the pitch of the patient.
DiScuSSion
The dosimetric influence of a tilt in the patient position during 
the treatment compared to the initial treatment plan was evalu-
ated for patients with NPC and esophageal cancer. The influence 
of a tilt by 1.5° and 3° in ventral and dorsal direction was clin-
ically relevant for nasopharyngeal volumes but not for esopha-
geal volumes. For esophageal cancer patients, all treatment plans 
were clinically acceptable with a pitch of ± 1.5° and ± 3°. For 
patients with NPC, 4/10 plans initially exceeded the organ toler-
ance dose of at least one OAR compared to 21/40 tilted plans, 
Figure 2.  Mean deviation in maximum and mean dose of the PTV and PTV coverage for pitch of ±1.5° and ±3° in NPC (a) and 
esophageal cancer patients (b). Error bars are showing one standard deviation. Positive value = ventral pitch, negative value = 
dorsal pitch. Dev, deviation; NPC, nasopharyngeal carcinoma; PTV, planning target volume; SD, standard deviation; V95%, dose 
which covers 95% of the PTV.
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especially with a pitch of 3°. For nasopharyngeal volumes, it is 
therefore useful to correct a pitch with a 6DoF treatment couch 
or with repositioning of the patient. This is especially important 
for patients where a dose constraint is already exceeded or 
near the tolerance level in the initial treatment plan. The PTV 
coverage was only slightly affected by a pitch of up to 3° with a 
mean dose variation of at maximum 2.6% for both nasopharyn-
geal and esophageal cancer patients. As dose constrains for OAR 
are always prioritized over PTV coverage, there was no partic-
ular institutional dose constraint for that.
Several studies exist evaluating the influence of a patient’s tilt on 
the dose distribution for intra- and extracranial stereotactic as 
well as for prostate volumes.1,2,4,14 All of these studies showed 
minor deviation in dose to the OAR and PTV coverage for a 
rotational misalignment of up to 3°. However, very few studies 
exist evaluating the effect of a rotational misalignment for long 
treatment volumes.3,15 Since a rotational error of 3° corresponds 
to a lateral offset of 0.5 mm 1 cm away from the center of the 
target and of 5.2 mm 10 cm away, the largest effect of a rota-
tional misalignment is expected for long treatment volumes. 
Guckenberger et al evaluated the influence of rotational setup 
errors for different treatment sites. They found that rotational 
errors were only of clinical relevance in patients with elon-
gated, non-spherical target volumes and sharp dose gradients 
to adjacent OAR.3 Similarly, Fu et al showed that the coverage 
of the clinical target volume in head and neck cancer patients 
can decrease as much as 9.8% for individual fractions, assuming 
realistic set-up errors of up to 5°.15 We compared two different 
treatment sites with large target volumes. Interestingly, we could 
show that for esophageal cancer the effect on the target coverage 
and the change in dose to the OAR of a rotational error is much 
smaller compared to NPC. The PTV coverage is less affected in 
esophageal tumor volumes, because the main dose contribution 
comes from anterior and posterior direction in order to spare the 
lung tissue. Whereas a tilt in ventral or dorsal direction could 
have a large influence on the target coverage for lateral fields, 
there is only a minor influence for anterior and posterior fields. 
In contrast, for head and neck volumes a large dose contribu-
tion comes from lateral fields. Mainly, for the same reason the 
change in dose to the OAR is smaller for esophageal treatment 
volumes compared to head and neck treatment volumes. In 
Table 3.  Mean dose deviation in NPC patients dependent on degree and direction of pitch
Dose deviation NPC [%]
3° ventral 1.5° ventral 1.5° dorsal 3° dorsal
PTV
  PTV1 max −0.1 (0.6) n.s. 4.5 (7.3) n.s. −3.8 (4.9) n.s. −4.6 (7.8) n.s.
  PTV1 mean −0.1 (0.2) n.s. 1.9 (5.4) n.s. −1.4 (3.8) n.s. −1.0 (6.1) n.s.
  PTV3 max 1.8 (3.0) n.s. −0.3 (1.9); n.s. 0.5 (1.3) n.s. 1.7 (4.1) n.s.
  PTV3 mean 0.8 (2.3) n.s. 0.45 (1.1) p = 0.022 −0.4 (0.9) p = 0.022 −1.2 (3.1) p = 0.013
  PTV1 V95% −2.6 (3.0) p = 0.013 −0.5 (1.1) n.s. −0.8 (1.0) n.s. −2.2 (2.2) p = 0.017
  PTV3 V95% −2.0 (2.3) p = 0.022 −0.6 (1.2) n.s. −1.0 (0.9) p = 0.013 −1.9 (1.7) p = 0.009
OAR
  Chiasm max 5.8 (9.7) n.s. 4.5 (7.3) n.s. −3.8 (4.9) n.s. −4.6 (7.8) n.s.
  Chiasm mean 3.0 (7.7) n.s. 1.9 (5.4) n.s. −1.4 (3.8) n.s. −1.0 (6.1) n.s.
  Brain mean −1.3 (2.7) n.s. −0.3 (1.9) n.s. 0.5 (1.3) n.s. 1.7 (4.1) n.s.
  Brainstem max −3.7 (3.3) p = 0.013 −1.7 (1.9) p = 0.037 2.9 (3.1) p = 0.022 6.0 (6.3) p = 0.017
  Brainstem mean −2.4 (4.0) p = 0.028 −0.7 (2.5) n.s. 1.3 (2.3) p = 0.047 3.0 (5.5) p = 0.037
  Lens max (i) 3.3 (3.0) p = 0.022 2.5 (2.5) p = 0.017 −1.4 (2.1) n.s. −2.3 (2.9) p = 0.037
  Lens max (c) 3.1 (3.3) p = 0.037 1.9 (2.7) n.s. −1.0 (1.6) n.s. −1.1 (3.3) n.s.
  Spinal cord max −3.9 (5.2) p = 0.028 −2.2 (3.0) p = 0.047 5.1 (4.2) p = 0.017 10.0 (9.9) p = 0.013
  Spinal cord mean −0.5 (3.2) n.s. −0.6 (0.6) p = 0.013 1.9 (3.5) p = 0.013 3.1 (4.1) p = 0.013
  Oral mucosa mean 2.6 (2.5) p = 0.022 1.0 (1.3) n.s. −1.6 (1.3) p = 0.013 −2.8 (3.0) p = 0.017
  Parotid gland mean (i) 4.0 (4.1) p = 0.017 2.0 (2.2) p = 0.022 −1.2 (2.0) p = 0.047 −3.1 (3.2) p = 0.014
  Parotid gland mean (c) 4.3 (4.0) p = 0.007 1.8 (1.7) p = 0.013 −2.0 (1.8) p = 0.009 −3.1 (3.2) p = 0.013
  Optical nerve max (i) 1.0 (14.2) n.s. −0.6 (13.2) n.s. −3.0 (4.8) n.s. −3.4 (5.5) n.s.
  Optical nerve max (c) 1.6 (15.1) n.s. 0.3 (14.2) n.s. −3.5 (3.8) p = 0.047 −3.7 (7.7) n.s.
c, contralateral; i, ipsilateral; NPC, nasopharyngeal carcinoma; n.s., not significant; PTV, planning target volume; V95%, dose which covers 95% of 
the PTV.
Patients were tilted ventrally and dorsally by 1.5° and 3°. Standard deviations are shown in bracket.
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addition, in the case of head and neck treatment volumes OAR 
are usually closer to the PTV and therefore are more prone to 
setup errors due to rotations. This is the first study showing that 
the treatment technique significantly influences the robustness 
against rotational set-up errors and that therefore, the benefit of 
compensation with a 6DoF couch has to be carefully evaluated 
per treatment site.
Since the dose to the OAR in NPC patients is usually already 
near the tolerance level, a minor difference in dose could lead to 
severe side effects. Radiation-induced toxicity is already high in 
NPC patients with acute toxic reactions of the oral mucosa, sali-
vary glands and skin. Incidence rates for acute radiation induced 
grade 3 toxicities are reported for mucositis (35%), dysphagia 
(11%), xerostomia (6%) and skin reactions (4%). Late radiation 
induced toxicity is less common with 3% grade 3 xerostomia.16 
In esophageal cancer, dose to the PTV is much less compared 
to the dose for NPC patients with up to 54 Gy, so no extensive 
toxicity is expected for lung and spinal cord when there is a 
minor dose variation.
In this study we analyzed the impact of pitch but not of roll or 
yaw. In addition, translational set-up errors were not evaluated 
because they can be compensated with help of on-board imaging 
and currently available 4DoF tables integrated in modern linear 
accelerators. The effect of roll of the patient was expected to be 
less compared to pitch due to the smaller extension of the PTVs 
in that direction. Kim et al evaluated the dosimetric changes due 
to a roll of 3° in intensity modulated radiotherapy plans of head 
and neck cancer patients and found an average increase in the 
maximum dose to the spinal cord of 3.1% but no effect on the 
dose to the parotid glands.17 Our study on the effect of a 3° pitch 
on the dosimetry of NPC VMAT plans showed a larger average 
change in the maximum dose to the spinal cord of −3.9% (3° 
ventral) / 10.0% (3° dorsal) and an average change of the mean 
dose of −0.5% (3° ventral) / 3.1% (3° dorsal). Several studies have 
shown pitch and roll values for head and neck cancer patients of 
up to 14°.7–10 In this study, we have evaluated the effect of a pitch 
of ± 1.5° and ± 3°. The effect of a 14° pitch is expected to be much 
higher. Nevertheless, we have decided to only evaluate the effect 
of up to 3°, because most of the available 6DoF treatment tables 
are not able to adjust more than 3°. According to our current 
clinical protocol, we would correct for a pitch or roll between 
1° and 3° by means of the rotational degrees of freedom of the 
couch. Deviations of more than 3° would induce us to reposi-
tion the patient. Additionally, it was shown by several studies 
Figure 3.  Box-Whisker-Plots showing percentage changes in dose to OAR in NPC patients if the patient is tilted ventrally (a–b) 
and dorsally (c–d) by 1.5° and 3°. c, contralateral; i, ipsilateral; NPC, nasopharyngeal carcinoma; OAR, organs at risk.
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Figure 4.  Dose distribution of the original plan (left) and the 
plan on the 3° tilted CT data set in dorsal direction (right). 
The dose to the brainstem (light blue) increased with the 
pitch because the high dose area of the PTV1 (in red) shifted 
towards the brainstem.
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